HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Besterman, J. M. Articles by Cuatrecasas, P. Search for Related Content PubMed PubMed Citation Articles by Besterman, J. M. Articles by Cuatrecasas, P. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 2, 723-727, 01, 1986

Lack of association of epidermal growth factor-, insulin-, and serum- induced mitogenesis with stimulation of phosphoinositide degradation in BALB/c 3T3 fibroblasts

JM Besterman, SP Watson and P Cuatrecasas

The hypothesis that inositol phospholipid degradation is a step in the mechanism by which epidermal growth factor (EGF) stimulates mitogenesis in confluent monolayers of quiescent BALB/c 3T3 fibroblasts was tested. The maximum mitogenic response (a nearly 30-fold increase in incorporation of [3H]thymidine) occurred at 1 ng/ml EGF (0.16 nM). This degree of stimulation corresponded to 60% of that elicited by 10% serum. To determine whether EGF stimulated formation of inositol phosphates via degradation of polyphosphoinositides, the intracellular levels of [3H] inositol phosphates and [3H]phosphoinositides were determined after EGF addition to BALB/c 3T3 fibroblasts prelabeled with [3H]inositol. These experiments were performed under conditions designed to mimic exactly those conditions used to study mitogenesis. The results demonstrated that 10% serum or 10 ng/ml of platelet-derived growth factor, but not as much as 50 ng/ml EGF or 10 micrograms/ml insulin, increased the levels of inositol phosphates via degradation of phosphoinositides in the presence of 10 mM Li+. The serum-induced effects occurred in 30 s, the earliest time investigated. Phorbol dibutyrate (100 nM), alone or in conjunction with EGF (10 ng/ml), failed to stimulate inositol phospholipid degradation. However, phorbol dibutyrate inhibited the serum-induced stimulation. Finally, fetal bovine serum dialyzed so as to retain peptide mitogens lost almost 70% of the capacity to stimulate degradation of inositol phospholipids while remaining as mitogenic as the control serum. Thus, stimulation of inositol phospholipid degradation is an unlikely component in the mechanism by which EGF and probably insulin and serum stimulate mitogenesis in BALB/c 3T3 fibroblasts.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E.-J. Yeo and J. H. Exton Stimulation of Phospholipase D by Epidermal Growth Factor Requires Protein Kinase C Activation in Swiss 3T3 Cells J. Biol. Chem., February 24, 1995; 270(8): 3980 - 3988. [Abstract] [Full Text] [PDF]

				A Sewing, C Burger, S Brusselbach, C Schalk, F. Lucibello, and R Muller Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP J. Cell Sci., January 2, 1993; 104(2): 545 - 555. [Abstract] [PDF]

				B Margolis, A Zilberstein, C Franks, S Felder, S Kremer, A Ullrich, S. Rhee, K Skorecki, and J Schlessinger Effect of phospholipase C-gamma overexpression on PDGF-induced second messengers and mitogenesis Science, May 4, 1990; 248(4955): 607 - 610. [Abstract] [PDF]

				J. Pierce, M Ruggiero, T. Fleming, P. Di Fiore, J. Greenberger, L Varticovski, J Schlessinger, G Rovera, and S. Aaronson Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells Science, February 5, 1988; 239(4840): 628 - 631. [Abstract] [PDF]

				K Matuoka, K Fukami, O Nakanishi, S Kawai, and T Takenawa Mitogenesis in response to PDGF and bombesin abolished by microinjection of antibody to PIP2 Science, February 5, 1988; 239(4840): 640 - 643. [Abstract] [PDF]